Use of bioengineered human commensal gut bacteria-derived microvesicles for mucosal plague vaccine delivery and immunization. (2019)
Attributed to:
Application of a commensal gut bacterium for the controlled delivery of heterologous proteins to the lower GI tract
funded by
BBSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1111/cei.13301
PubMed Identifier: 30985006
Publication URI: http://europepmc.org/abstract/MED/30985006
Type: Journal Article/Review
Volume: 196
Parent Publication: Clinical and experimental immunology
Issue: 3
ISSN: 0009-9104